You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Heplisav-B

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders

Completed
  • HIV Infections
  • +2 more
    • Baltimore, Maryland
    • +1 more
    Mar 17, 2023

    Hepatitis B, Cirrhosis, Liver, Chronic Liver Disease Trial in Baltimore (Heplisav-B Injectable Product, 2-dose regimen,

    Recruiting
    • Hepatitis B
    • +2 more
    • Heplisav-B Injectable Product, 2-dose regimen
    • Heplisav-B Injectable Product, 3-dose regimen
    • Baltimore, Maryland
      Mercy Medical Center
    Aug 24, 2022

    Pregnant Trial in Wilmington (HEPLISAV-B)

    Recruiting
    • Pregnant
    • HEPLISAV-B
    • Wilmington, North Carolina
      PPD Registry Office, Recruiting Nationwide
    Mar 31, 2022

    Hepatitis B Trial in Dallas (Heplisav-B)

    Completed
    • Hepatitis B
    • Heplisav-B
    • Dallas, Texas
      Baylor Scott & White Research Institute
    Feb 24, 2022

    Hepatitis, Safety and Tolerability Trial run by the NHLBI (HEPLISAV-B)

    Completed
    Has Results
    • Hepatitis
    • Safety and Tolerability
    • HEPLISAV-B
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 13, 2022

    Lymphoma Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (PNEUMOVAX 23, Fluarix, FluLaval)

    Recruiting
    • Lymphoma
    • PNEUMOVAX 23
    • +9 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    Chronic Hepatitis B Trial in Hamburg (HEPLISAV B; TherVacB, TherVacB)

    Not yet recruiting
    • Chronic Hepatitis B
    • HEPLISAV B; TherVacB
    • TherVacB
    • Hamburg, Germany
      CTC North
    Feb 3, 2023

    Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])

    Withdrawn
    • Hepatitis B
    • Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
    • Baltimore, Maryland
    • +1 more
    Jul 19, 2022

    Chronic Kidney Disease Trial in Norfolk (HEPLISAV-B, Engerix-B, Placebo)

    Completed
    Has Results
    • Chronic Kidney Disease
    • HEPLISAV-B
    • +2 more
    • Norfolk, Virginia
      Clinical Research Associates of Tidewater
    Apr 28, 2021

    HIV Infection, Hepatitis B Trial in Worldwide (HEPLISAV-B, ENGERIX-B)

    Recruiting
    • HIV Infection
    • Hepatitis B
    • HEPLISAV-B
    • ENGERIX-B
    • Birmingham, Alabama
    • +47 more
    Dec 13, 2022

    Hepatitis B Virus Trial (Adjuvanted Hepatitis B Vaccine)

    Withdrawn
    • Hepatitis B Virus
    • Adjuvanted Hepatitis B Vaccine
    • (no location specified)
    Apr 27, 2021

    End Stage Renal Disease on Dialysis (Diagnosis) Trial in United States (HEPLISAV-B®)

    Unknown status
    • End Stage Renal Disease on Dialysis (Diagnosis)
    • Bloomfield, Connecticut
    • +19 more
    Dec 14, 2020

    Hepatitis B Trial in United States (HEPLISAV)

    Completed
    Has Results
    • Hepatitis B
    • HEPLISAV
    • Boardman, Ohio
    • +6 more
    Apr 16, 2019

    Hepatitis B Trial in Canada, Germany (HEPLISAV and/or Placebo, Engerix-B)

    Completed
    Has Results
    • Hepatitis B
    • HEPLISAV and/or Placebo
    • Engerix-B
    • Edmonton, Alberta, Canada
    • +17 more
    Mar 18, 2019

    Immunogenicity of HEPLISAV™ and Engerix-B® in Chronic Kidney

    Completed
    • Chronic Kidney Disease
    • HEPLISAV
    • Engerix-B
    • Norfolk, Virginia
      Clinical Research Associates of Tidewater
    Mar 18, 2019

    Hepatitis B Trial in Lenexa (HEPLISAV)

    Completed
    • Hepatitis B
    • HEPLISAV
    • Lenexa, Kansas
      Johnson County Clinical Trials
    Mar 18, 2019

    Healthcare Worker, Hepatitis B Vaccine, Nonresponder Trial in Madison (Recombinant hepatitis B vaccine with CpG adjuvant)

    Recruiting
    • Healthcare Worker, Hepatitis B Vaccine, Nonresponder
    • Recombinant hepatitis B vaccine with CpG adjuvant
    • Madison, Wisconsin
      University of Wisconsin
    Jul 5, 2022

    Hepatitis B Trial in St Johns, Halifax, Montreal (1018 ISS-HBsAg-Single, 1018 ISS-HBsAg-Double)

    Terminated
    • Hepatitis B
    • 1018 ISS-HBsAg-Single
    • 1018 ISS-HBsAg-Double
    • St Johns, Newfoundland and Labrador, Canada
    • +2 more
    Mar 18, 2019

    End Stage Renal Disease Trial in Germany (HEPLISAV, Engerix-B, Fendrix)

    Completed
    • End Stage Renal Disease
    • HEPLISAV
    • +2 more
    • Aschaffenburg, Germany
    • +18 more
    Mar 18, 2019

    Healthy Trial in United States (HEPLISAV, Engerix-B)

    Completed
    Has Results
    • Healthy
    • HEPLISAV
    • Engerix-B
    • Birmingham, Alabama
    • +39 more
    Mar 18, 2019

    Hepatitis B Trial in United States (1018 ISS immunostimulatory oligonucleotide with HBV surface antigen, Hepatitis B Vaccine

    Completed
    • Hepatitis B
    • 1018 ISS immunostimulatory oligonucleotide with HBV surface antigen
    • Hepatitis B Vaccine (Recombinant)
    • Costa Mesa, California
    • +3 more
    Mar 18, 2019

    Healthy Trial in Canada, United States (HEPLISAV and/or Placebo, Engerix-B)

    Completed
    Has Results
    • Healthy
    • HEPLISAV and/or Placebo
    • Engerix-B
    • Huntsville, Alabama
    • +31 more
    Mar 18, 2019

    COVID-19 Trial in Cali (VLA 2001)

    Not yet recruiting
    • COVID-19
    • VLA 2001
    • Cali, Valle, Colombia
      Centro de Estudios en Infectología Pediátrica
    Sep 15, 2022

    Pertussis/Whooping Cough Trial in Southampton (Bordetella pertussis B1917, Azithromycin Pill)

    Recruiting
    • Pertussis/Whooping Cough
    • Bordetella pertussis B1917
    • Azithromycin Pill
    • Southampton, Hampshire, United Kingdom
      NIHR Clinical Research Facility
    Apr 26, 2023

    Fibronectin Type ? Domain Containing Protein 5 \ Irsin Gene

    Recruiting
    • Hepatitis B, Chronic
    • genotyping
    • Sohag, Egypt
      Sohag university Hospital
    Sep 4, 2023